Study to Assess the Safety of Dupilumab (REGN668/SAR231893) Administered Concomitantly With Topical Corticosteroids (TCS) in Patients With Moderate-to-severe Atopic Dermatitis (AD)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
The purpose of this study was to assess the safety of Dupilumab administered concomitantly with topical corticosteroids (TCS) in patients with moderate-to-severe atopic dermatitis (AD).
Epistemonikos ID: dd98523cf8cb0fbdd3c82aeed1254a31ff089b9d
First added on: May 11, 2024